Media

Support Of Industry Underscores Pro-Business Commitment
2014 Livestock Biotech Summit three day programming touched on issues such as engaging consumers, animal welfare, the promise of the technology.

Press Releases

Jul 25 2000
WASHINGTON, D.C. (July 25, 2000) The Biotechnology Industry Organization (BIO) today applauded dismissal in federal court of a Greenpeace lawsuit against...
Jul 21 2000
WASHINGTON, D.C. (July 21, 2000) A Biotechnology Industry Organization (BIO) survey found that more than one-quarter billion people worldwide have benefited...
Jul 20 2000
(Carl B. Feldbaum, president of the Biotechnology Industry Organization [BIO] issued the following statement today regarding the formation of the Congressional...
Jul 18 2000
WASHINGTON, D.C. (July 18, 2000)- Biotechnology IndustryOrganization (BIO) President Carl B. Feldbaum said BIO supports the FDA’s powers regarding...
Jul 13 2000
WASHINGTON, D.C. (July 13, 2000) Executives from two Biotechnology Industry Organization (BIO) member companies testified today at a U.S. House Judiciary...
Jul 12 2000
WASHINGTON, D.C. (July 12, 2000) - Executives from two Biotechnology Industry Organization (BIO) member companies will testify Thursday, July 13, at a U.S....
Jul 11 2000
WASHINGTON, D.C. (July 11, 2000) - The Biotechnology Industry Organization (BIO) endorses recommendations contained in a report, released today, from the U.S....
Jun 30 2000
(Dr. Val Giddings, vice president for food and agriculture of the Biotechnology Industry Organization (BIO) issued the following statement in response to today...
Jun 29 2000
WASHINGTON, D.C. (June 29, 2000) - Nancy Myers, health-care policy counsel for the Biotechnology Industry Organization (BIO), said House approval of a...


Biotechnology News

September 30, 2014

EXTON, Pa.--(BUSINESS WIRE)--Fibrocell Science, Inc., (NASDAQ:FCSC), an autologous cell therapy company focused on developing first-in-class treatments for rare and...

September 30, 2014

REDWOOD CITY, Calif.--(BUSINESS WIRE)--PaxVax, Inc., a specialty vaccine company focused on travel and biodefense, today announced that company Chief Executive Officer Ken...

September 30, 2014

RESEARCH TRIANGLE PARK, N.C.--(BUSINESS WIRE)--NephroGenex, Inc. (NASDAQ:NRX), a pharmaceutical company focused on the development of therapeutics to treat kidney disease...

September 30, 2014

SAN DIEGO & VANCOUVER, British Columbia--(BUSINESS WIRE)--Sophiris Bio Inc., a biopharmaceutical company developing PRX302 for the treatment of the symptoms of benign...

September 30, 2014

RESEARCH TRIANGLE PARK, N.C.--(BUSINESS WIRE)--Quintiles Transnational Holdings Inc. (NYSE: Q) will release its third-quarter 2014 financial results Thursday, October 30,...